Patents (1304 Stem Cell Patents)

Class: Mobilization (25)

Order by:
1 2 3 | > | >>


Methods to mobilize progenitor/stem cells

Patent Number: 7,169,750

The reason why bone marrow cells home into the bone after intravenous administration is because a continuous production of Stromal Derived Factor-1 (SDF-1) by the bone marrow stromal compartments. The gradient of SDF-1 is also retains the early CD34+ bone marrow hematopoietic stem cells in the bone marrow. The current patent covers...

Inventors: Bridger; Gary (Bellingham, WA), Abrams; Michael J. (Custer, WA), Henson; Geoffrey W. (Ferndale, WA), MacFarland; Ronald T. (Vancouver, CA), Calandra; Gary B. (Cresco, PA)
Assignee: Anormed, Inc. (Langley, CA)
Date of First Priority Issue: Sunday February 4th, 2007

Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

Patent Number: 7,241,812

It is known that Sphingosine-1-phosphate mediates migration of mesenchymal stem cells. However, there are numerous receptors by which the effects of sphingosine-1-phosphate are mediated. While the sphingosine-1-phosphate receptor 1 is associated with migration, other activation of other receptors (such as sphingosine-1-phosphate...

Inventors: Saha; Ashis K. (Stow, MA), Kavarana; Malcolm J. (Burlington, MA), Evindar; Ghotas (Waltham, MA), Satz; Alexander L. (Needham, MA), Morgan; Barry (Franklin, MA)
Assignee: Praecis Pharmaceuticals, Inc. (Waltham, MA)
Date of First Priority Issue: Friday August 13th, 2004

G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Patent Number: 7,220,407

Subsequent to myocardial infarction, cells of the injured myocardium release a variety of cytokines and mediators that are involved in mobilizing endogenous bone marrow stem cells and inducing their migration to the area of myocardial injury. One cytokine released is G-CSF, which in addition to possessing hematopoietic functions also is a great mobilizer of stem cells. In the current...

Inventors: Mehta; Jayesh (Chicago, IL), Singhal; Seema (Chicago, IL), Davidson; Charles (Winnetka, IL), Beohar; Nirat (Chicago, IL), Bonow; Robert (Glencoe, IL)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Date of First Priority Issue: Monday October 27th, 2003

Hematopoietic stem cells treated by in vitro fucosylation and methods of use

Patent Number: 7,332,334

On of the interesting methods of manipulating stem cells is to increase their ability to “go where they are suppose to”. For example, it is known that when bone marrow or cord blood hematopoietic stem cells are injected intravenously into an irradiated recipient, the cells selectively home to the bone marrow and if enough cells migrate appropriately, hematopoietic reconstitution...

Inventors: Xia; Lijun (Edmond, OK), McEver; Rodger P. (Oklahoma City, OK)
Assignee: Oklahoma Medical Research Foundation (Oklahoma City, OK)
Date of First Priority Issue: Friday April 18th, 2003

Chemokine analogs for the treatment of human disease

Patent Number: 7,091,310

This patent is useful for stem cell mobilization, stem cell homing, as well as a variety of other applications involving various chemokines. Specifically, the invention covers peptides that antagonize or agonize receptors for IL-8, IP-10, MIP-1 alpha., MCP-1, RANTES, I-309, and CCL28. Inventors: Merzouk, Ahmed (Richmond, CA); Wong, Donald (Vancouver, CA); Salari, Hassan (Delta, CA)

Assignee: Chemokine Therapeutics Corporation (Vancouver, CA)
Date of First Priority Issue: Friday September 13th, 2002

Regulation of cytotrophoblast cell differentiation and cell migration

Patent Number: 7,244,707

Although this patent describes modulation of stem cell migration in the specification, the claims are restricted to the regulation of placental size. Specifically, the patent claims the use of IGF-2 to augment "placental growth, placental function, placental development and placental differentiation" in a mammal. The inventors appear to be the first to discover...

Inventors: Roberts; Claire (Adelaide, AU), Owens; Phillip (Cheongju, KR)
Assignee: Adelaide Research & Innovation Pty Ltd (South Australia, AU)
Date of First Priority Issue: Friday August 30th, 2002

Methods and compositions for directing cells to target organs

Patent Number: 7,282,222

This patent covers the use of various carbohydrate presenting molecules for increasing amount of stem cell homing to tissue where stem cell migration is desired. Specific molecules that attract the stem cells which are covered include asialoorosomucoid and orosomucoid. This patent could be used to not only augment currented CD34 stem cell therapy efficacy but...

Inventors: Phillips; Catherine (Amarillo, TX)
Assignee: The United States of America as Represented by the Department of Veterans Affairs (Washington, DC)
Date of First Priority Issue: Friday March 15th, 2002

Methods to mobilize progenitor/stem cells

Patent Number: 6987102

Hematopoietic stem cells stay in the bone marrow due in part to secretion of SDF-1 by bone marrow stromal cells. The chemotactic gradient of SDF-1 is also what causes hematopoietic stem cells to home to the bone marrow of the recipient after a bone marrow transplant. This invention covers some antagonists of the receptor for Inventors: Bridger, Gary J. (Bellingham, WA); Abrams, Michael J. (Custer, WA); Henson, Geoffrey W. (Ferndale, WA); MacFarland, Ronald Trevor (Vancouver, CA); Calandra, Gary B. (Cresco, PA); Broxmeyer, Hal E. (Indianapolis, IN); Dale, David C. (Seattle, WA)

Assignee: Anormed, Inc. (Langley, CA)
Date of First Priority Issue: Tuesday July 31st, 2001

Method for enhancing stem cell trafficking

Patent Number: 6814961

This patent teaches the use of a naturopathic remedy for actually mobilizing stem cells into systemic circulation. The naturopathic remedy is blue green algae. This patent may be used for treating anything that benefits from mobilized stem cells ranging from stroke to myocardial infarction.

Inventors: Jensen, Gitte S. (Port Dover, Ontario, CA); Drapeau, Christian (Keno, OR)
Assignee: None Stated
Date of First Priority Issue: Monday May 14th, 2001

CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis

Patent Number: 7,176,243

The area of stem cell mobilization is very exciting not only from the perspective of allowing for efficient harvest of peripheral blood stem cells, but also from the perspective of one day being able to mobilize endogenous stem cells to accelerate healing of various organs. In this patent a novel method of inducing mobilization of stem cells from the bone marrow, as well as inhibiting...

Inventors: Poznansky; Mark C. (Charlestown, MA), Scadden; David T. (Weston, MA), Olszak; Ivona T. (Charlestown, MA), Brown; Edward M. (Milton, MA)
Assignee: The General Hospital Corporation (Boston, MA) The Brigham and Women's Hospital, Inc. (Boston, MA)
Date of First Priority Issue: Monday May 1st, 2000

Order by:
1 2 3 | > | >>





Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.01